A recent study indicates that individuals who discontinue popular slimming jabs like Mounjaro or Wegovy may regain lost weight at a significantly accelerated pace than those who end conventional lifestyle regimens.
Published data in a major medical journal demonstrates that while overweight people frequently drop about a fifth of their body weight while undergoing treatment, the mass comes back at an estimated rate of nearly a kilo each month upon discontinuation.
"Individuals using these drugs should be informed of the risk of fast rebound weight gain when the treatment concludes," stated researcher Dr. Susan Jebb.
That rate of regain implies a return to pre-treatment weight in about one and a half years.
Comparing Treatments
The analysis, which examined 37 of trials involving thousands of patients, contrasted the results of GLP-1 agonists with other pills.
Scientists point out that individuals who lose weight through dieting generally experience a slower creep back—perhaps 0.1 kg a month—after stopping.
The Reason for the Rapid Regain
Nutrition scientists suggest the way of the jabs accounts for the accelerated rebound.
These medications mimic a natural hormone called GLP-1, which controls hunger.
"Sustained high doses of GLP-1 concentrations several times higher than normal could lead to the body to produce less of its endogenous GLP-1, and may also diminish sensitivity to its effects," noted Dr. Adam Collins, a nutrition researcher.
"Withdrawal of this medication means hunger is uncontrolled, making binge eating a significant risk."
A Lifelong Issue?
Medical guidelines suggest the jabs for individuals with weight-linked health risks, alongside recommended diet and exercise modifications.
Many experts contend that, due to the significant potential of relapse, the treatment should be considered ongoing.
This view is reinforced by pharmaceutical companies, who say that the findings "underscore the persistent nature of excess weight," comparing it to managing diseases like hypertension.
User Testimonies
Individuals who have come off the jabs explain a powerful return of cravings.
"It felt as if a switch flipping and you become ravenous," described an individual.
This challenge is compounded if users have not established lasting dietary or behavioural modifications during therapy.
Widespread Interest
Figures show that a significant number of adults in the UK have tried these injections in the last 12 months, with desire being substantial.
- Adoption is more common among females compared to men.
- The 40s and 50s age group shows the highest usage rates.
- Many access the drugs through private healthcare rather than public health services.
Finally, experts caution that while the jabs are powerful tools for weight loss, they are not a standalone fix and lasting health benefits hinges on ongoing behavioural changes.
